Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(NY: KVUE )

22.73 -0.20 (-0.87%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about KVUE

< Previous 1 2 3 4 5 Next >
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
From Kenvue
Via Business Wire
Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
From Kenvue
Via Business Wire
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
Healthcare giant and Dividend Aristocrat Johnson & Johnson is on track to hit new highs in 2025 and may sustain its rally well into 2026. 
Via MarketBeat
Exposures COVID-19
Kenvue Drives Climate Action Strategy Forward
From Kenvue
Via Business Wire
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
From Kenvue
Via Business Wire
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Kenvue Reports Second Quarter 2024 Results
From Kenvue
Via Business Wire
Kenvue Announces Board Changes with Two New Independent Directors
From Kenvue
Via Business Wire
Kenvue Increases Quarterly Cash Dividend
From Kenvue
Via Business Wire
This Medical Giant's Stock Rebounds: A 15% Upside Is the Minimum
Johnson & Johnson reported a solid quarter for Q2 but issued mixed guidance. The critical detail is that sequential growth continues, and YOY growth is on tap. 
Via MarketBeat
Exposures COVID-19
Kenvue to Announce Second Quarter 2024 Results on August 6, 2024
From Kenvue
Via Business Wire
Kenvue Releases Inaugural Healthy Lives Mission Report
From Kenvue
Via Business Wire
Kenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer Conference
From Kenvue Inc.
Via Business Wire
Kenvue Announces Pricing of Secondary Offering
From Kenvue
Via Business Wire
Kenvue Announces Launch of Secondary Offering
From Kenvue Inc.
Via Business Wire
Kenvue Reports First Quarter 2024 Results
From Kenvue Inc.
Via Business Wire
Kenvue Declares Quarterly Cash Dividend
From Kenvue Inc.
Via Business Wire
Johnson & Johnson is as Cheap as it’s Going to Get
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely. 
Via MarketBeat
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend 
Via MarketBeat
Kenvue to Announce First Quarter 2024 Results on May 7, 2024
From Kenvue Inc.
Via Business Wire
Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting
From Kenvue Inc.
Via Business Wire
Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
From Kenvue Inc.
Via Business Wire
Kenvue Reports Full Year and Fourth Quarter 2023 Results
From Kenvue Inc.
Via Business Wire
KENVUE ALERT: Bragar Eagel & Squire, P.C. is Investigating Kenvue Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kenvue Declares Quarterly Cash Dividend
From Kenvue Inc.
Via Business Wire
3 personal care stocks that smell like good earnings plays
Management remarks about how they plan to use technology to drive growth could matter just as much as near-term financials for these personal care companies. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
From Kenvue Inc.
Via Business Wire
KVUE DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm – KVUE
From The Rosen Law Firm, P.A.
Via Business Wire
KVUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.